Why is Morepen Labs. falling/rising?

As of 11-Aug, Morepen Laboratories Ltd is experiencing a decline in its stock price, currently at 46.92, reflecting a decrease of 0.26 or 0.55%. The stock has been underperforming significantly, with a consecutive fall over the last five days resulting in a total return of -18.77% in that period. Additionally, it is trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages. The company has reported negative financial results in the last two quarters, with a notable drop in net sales of -8.72%, contributing to a year-over-year return of -19.28%. Despite having a low debt-to-equity ratio and an attractive valuation, the stock's poor long-term growth prospects and declining profits have led to a lack of confidence among investors, as evidenced by the negligible domestic mutual fund holdings.
In the broader market context, Morepen Laboratories Ltd's short-term performance has sharply diverged from the benchmark, with a 1-week return of -18.77% compared to the Sensex's modest decline of -0.51%. This stark contrast highlights the stock's significant underperformance relative to the market. While the overall market has shown resilience with a year-to-date gain of 3.15%, Morepen's substantial losses indicate a troubling trend that may deter potential investors. The combination of negative financial results, declining sales, and poor investor sentiment has contributed to the stock's downward trajectory, contrasting sharply with the broader market's performance.